Genome-wide DNA methylation profiles in both precancerous conditions and clear cell renal cell carcinomas are correlated with malignant potential and patient outcome

Carcinogenesis

Volumn 30, Issue 2, 2009, Pages 214-221

  Arai, Eri ^a   Ushijima, Saori ^a   Fujimoto, Hiroyuki ^b   Hosoda, Fumie ^a   Shibata, Tatsuhiro ^a   Kondo, Tadashi ^a   Yokoi, Sana ^c   Imoto, Issei ^c   Inazawa, Johji ^c   Hirohashi, Setsuo ^a   Kanai, Yae ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c Tokyo Medical and Dental University ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER RECURRENCE; CANCER STAGING; CLEAR CELL CARCINOMA; CLUSTER ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INHERITANCE; KIDNEY CARCINOMA; KIDNEY CORTEX; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRECANCER; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

AGED; CARCINOMA, RENAL CELL; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, ARTIFICIAL, BACTERIAL; CLUSTER ANALYSIS; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; KIDNEY CORTEX; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 60149106402     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn268     Document Type: Article

References (35)

1. Jones,P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
2. Eden,A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
3. Baylin,S.B. et al. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer, 6, 107-116.
4. Gronbaek,K. et al. (2007) Epigenetic changes in cancer. APMIS 115, 1039-1159.
5. Feinberg,A.P. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature, 447, 433-440.
6. Kanai,Y. et al. (2007) Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28, 2434-2442.
7. Kanai,Y. (2008) Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol. Int., 58, 544-558.
8. Estecio,M.R. et al. (2007) High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res., 17, 1529-1536.
9. Jacinto,F.V. et al. (2007) Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res., 67, 11481-11486.
10. Nielander,I. et al. (2007) Combining array-based approaches for the identification of candidate tumor suppressor loci in mature lymphoid neoplasms. APMIS, 115, 1107-1134.
11. Toyota,M. et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA, 96, 8681-8686.
12. Arai,E. et al. (2006) Regional DNA hypermethylation and DNA methyltransferase (DNMT) 1 protein overexpression in both renal tumors and corresponding nontumorous renal tissues. Int. J. Cancer, 119, 288-296.
13. Misawa,A. et al. (2005) Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res., 65, 10233-10242.
14. Sugino,Y. et al. (2007) Epigenetic silencing of prostaglandin E receptor 2 (PTGER2) is associated with progression of neuroblastomas. Oncogene, 26, 7401-7413.
15. Tanaka,K. et al. (2007) Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene, 26, 6456-6468.
16. Inazawa,J. et al. (2004) Comparative genomic hybridization (CGH)-arrays pave the way for identification of novel cancer-related genes. Cancer Sci., 95, 559-563.
17. Eble,J.N. et al. (2004) Renal Cell Carcinoma. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs, IARC Press, Lyon, 10-43.
18. Fuhrman,S.A. et al. (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol., 6, 655-663.
19. Sobin,L.H. et al. (2002) International Union Against Cancer (UICC). TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss, New York, NY, 193-195.
20. Kanai,T. et al. (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer, 60, 810-819.
21. Illingworth,R. et al. (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol. 6, e22.
22. Maekita,T. et al. (2006) High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res., 12, 989-995.
23. Frigola,J. et al. (2006) Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. Nat. Genet., 38, 540-549.
24. Christoph,F. et al. (2006) Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications. Clin. Cancer Res., 12, 5040-5046.
25. Urakami,S. et al. (2006) Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin. Cancer Res., 12, 6989-6997.
26. Ibanez de Caceres,I. et al. (2006) Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res., 66, 5021-5028.
27. Costa,V.L. et al. (2007) Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors. BMC Cancer, 7, 133.
28. Morris,M.R. et al. (2008) Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br. J. Cancer, 98, 496-501.
29. Arai,E. et al. (2008) Genetic clustering of clear cell renal cell carcinoma based on array-CGH: Its association with DNA methylation alteration and patient outcome. Clin. Cancer Res., 14, 5531-5539.
30. Jones,J. et al. (2007) Genomics of renal cell cancer: The biology behind and the therapy ahead. Clin. Cancer Res., 13, 685s-692s.
31. Guida,M. et al. (2007) Immunotherapy for metastatic renal cell carcinoma: Is it a therapeutic option yet? Ann. Oncol., 18 (suppl. 6), vi149-52.
32. Patel,P.H. et al. (2006) Targeting von Hippel-Lindau pathway in renal cell carcinoma. Clin. Cancer Res., 12, 7215-7520.
33. Kanai,Y. et al. (1996) Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis. Jpn. J. Cancer Res., 87, 1210-1217.
34. Eguchi,K. et al. (1997) DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history. Cancer Res., 57, 4913-4915.
35. Peng,D.F. et al. (2006) DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis, 27, 1160-1168.